BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 23449689)

  • 1. PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.
    Ryan JJ; Marsboom G; Fang YH; Toth PT; Morrow E; Luo N; Piao L; Hong Z; Ericson K; Zhang HJ; Han M; Haney CR; Chen CT; Sharp WW; Archer SL
    Am J Respir Crit Care Med; 2013 Apr; 187(8):865-78. PubMed ID: 23449689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
    Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
    Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.
    Dasgupta A; Chen KH; Lima PDA; Mewburn J; Wu D; Al-Qazazi R; Jones O; Tian L; Potus F; Bonnet S; Archer SL
    FASEB J; 2021 Aug; 35(8):e21771. PubMed ID: 34275172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dynamics in pulmonary arterial hypertension.
    Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
    J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
    Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
    Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.
    Yeligar SM; Kang BY; Bijli KM; Kleinhenz JM; Murphy TC; Torres G; San Martin A; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2018 May; 58(5):648-657. PubMed ID: 29182484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.
    Fang X; Chen X; Zhong G; Chen Q; Hu C
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):164-74. PubMed ID: 26485208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2.
    Lu Z; Li S; Zhao S; Fa X
    Med Sci Monit; 2016 Sep; 22():3301-8. PubMed ID: 27640178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In utero exposure to prepregnancy maternal obesity and postweaning high-fat diet impair regulators of mitochondrial dynamics in rat placenta and offspring.
    Borengasser SJ; Faske J; Kang P; Blackburn ML; Badger TM; Shankar K
    Physiol Genomics; 2014 Dec; 46(23):841-50. PubMed ID: 25336449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
    Zabini D; Granton E; Hu Y; Miranda MZ; Weichelt U; Breuils Bonnet S; Bonnet S; Morrell NW; Connelly KA; Provencher S; Ghanim B; Klepetko W; Olschewski A; Kapus A; Kuebler WM
    Am J Respir Crit Care Med; 2018 Jan; 197(2):244-260. PubMed ID: 29095649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
    Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
    Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
    Sutendra G; Dromparis P; Bonnet S; Haromy A; McMurtry MS; Bleackley RC; Michelakis ED
    J Mol Med (Berl); 2011 Aug; 89(8):771-83. PubMed ID: 21809123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
    Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
    Archer SL; Marsboom G; Kim GH; Zhang HJ; Toth PT; Svensson EC; Dyck JR; Gomberg-Maitland M; Thébaud B; Husain AN; Cipriani N; Rehman J
    Circulation; 2010 Jun; 121(24):2661-71. PubMed ID: 20529999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
    Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.